Hyperion DeFi, Inc. (NasdaqCM: HYPD)
Health Care · Pharmaceuticals · US
$3.45
+8.49% today · -47.9% 1Y
Hyperion DeFi, Inc. (NasdaqCM: HYPD) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $49.42M and employs 9 people.
Over the last twelve months the share price has lost 47.9%, trading between 2.34 and 15.00.
Tweenvest scores Hyperion DeFi, Inc. across four factors: quality 27/100, value 49/100. Its strongest factor is value.
HYPD price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $49.42M
- Revenue (TTM)
- $1.40M
- P/E
- —
- EPS
- -1.83
- Dividend yield
- —
- Beta (5Y)
- 2.50
- 52-week high
- $15.00
- 52-week low
- $2.34
- Avg volume (3M)
- —
- Shares outstanding
- 15.54M
- Employees
- 9
- Next earnings
- —
About Hyperion DeFi, Inc.
Operating from the United States, Hyperion DeFi, Inc. is a company undergoing a significant shift from its foundational work in ophthalmic drug-delivery, known as Optejet. Its current trajectory involves establishing itself as the inaugural U.S. firm on Nasdaq to hold a cryptocurrency treasury, predominantly denominated in HYPE tokens originating from the Hyperliquid blockchain. Furthermore, Hyperion DeFi oversees the "Kinetiq × Hyperion" validator, persists with its decentralized finance (DeFi) staking strategies, and continues to advance its Optejet UFD™ technology for ocular health.
- ISIN
- US30234E2037
- Founded
- 2014
- Listed since
- Jan 25, 2018
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,237.79 | -0.73% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.44 | +0.15% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $156.08 | +3.60% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.37 | +1.41% |
Figures last refreshed Aug 18, 2026.